A single dose of mivocabtagene autoleucel (miv-cel), an autologous CD19 chimeric antigen receptor (CAR)-T cell therapy, ...
Lab-grown dopamine cells show early success in Parkinson’s patients, improving movement and offering a new treatment path.
There is new research happening at Roswell Park Comprehensive Cancer Center to see if CAR T-cell therapy that has worked for ...
The Maryland-area community oncology practice has developed one of the first outpatient, community-based T-cell-engaging programs, expanding access to advanced therapies, including bispecifics and CAR ...
Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in Australia, had been struggling with a ...
InVita Healthcare Technologies, a leader in blood and other biologics software, and Gulf Coast Blood, one of the nation's ...
CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine ...
Cerebral Palsy Center reports Kidswell Bio is advancing stem cell therapy for cerebral palsy in the U.S., focusing on cells ...
Worth up to $7 billion, Lilly’s second recent acquisition of a company in the space is centered around a cell therapy that’s ...
On Tuesday, the first person in the state to receive gene therapy for sickle cell disease left the hospital after a ...
SAN DIEGO - An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy ...
Metabolic tumor volume--a biomarker derived from PET imaging--can more accurately predict progression-free survival for large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results